Vanguard Group’s PDS Biotechnology PDSB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Buy |
1,951,343
+441,122
| +29% | +$587K | ﹤0.01% | 3446 |
|
|
2025
Q1 | $1.8M | Buy |
1,510,221
+4,409
| +0.3% | +$5.25K | ﹤0.01% | 3522 |
|
|
2024
Q4 | $2.45M | Sell |
1,505,812
-15,731
| -1% | -$25.6K | ﹤0.01% | 3498 |
|
|
2024
Q3 | $5.81M | Buy |
1,521,543
+112,704
| +8% | +$431K | ﹤0.01% | 3212 |
|
|
2024
Q2 | $4.13M | Sell |
1,408,839
-178,967
| -11% | -$524K | ﹤0.01% | 3334 |
|
|
2024
Q1 | $6.29M | Buy |
1,587,806
+82,135
| +5% | +$325K | ﹤0.01% | 3202 |
|
|
2023
Q4 | $7.48M | Sell |
1,505,671
-2,020
| -0.1% | -$10K | ﹤0.01% | 3110 |
|
|
2023
Q3 | $7.61M | Sell |
1,507,691
-117,456
| -7% | -$593K | ﹤0.01% | 3052 |
|
|
2023
Q2 | $8.17M | Buy |
1,625,147
+326,672
| +25% | +$1.64M | ﹤0.01% | 3064 |
|
|
2023
Q1 | $7.99M | Buy |
1,298,475
+136,950
| +12% | +$842K | ﹤0.01% | 3065 |
|
|
2022
Q4 | $15.3M | Buy |
1,161,525
+13,447
| +1% | +$178K | ﹤0.01% | 2755 |
|
|
2022
Q3 | $3.41M | Buy |
1,148,078
+54,193
| +5% | +$161K | ﹤0.01% | 3518 |
|
|
2022
Q2 | $3.99M | Hold |
1,093,885
| – | – | ﹤0.01% | 3494 |
|
|
2022
Q1 | $6.77M | Buy |
1,093,885
+79,025
| +8% | +$489K | ﹤0.01% | 3365 |
|
|
2021
Q4 | $8.22M | Buy |
1,014,860
+37,158
| +4% | +$301K | ﹤0.01% | 3336 |
|
|
2021
Q3 | $14.6M | Buy |
977,702
+14,200
| +1% | +$212K | ﹤0.01% | 3038 |
|
|
2021
Q2 | $12.1M | Buy |
963,502
+102,512
| +12% | +$1.29M | ﹤0.01% | 3113 |
|
|
2021
Q1 | $3.92M | Buy |
860,990
+146,953
| +21% | +$669K | ﹤0.01% | 3654 |
|
|
2020
Q4 | $1.53M | Buy |
714,037
+130,211
| +22% | +$279K | ﹤0.01% | 3722 |
|
|
2020
Q3 | $1.36M | Buy |
583,826
+569,077
| +3,858% | +$1.33M | ﹤0.01% | 3591 |
|
|
2020
Q2 | $30K | Sell |
14,749
-20,105
| -58% | -$40.9K | ﹤0.01% | 4048 |
|
|
2020
Q1 | $25K | Sell |
34,854
-1,352
| -4% | -$970 | ﹤0.01% | 4037 |
|
|
2019
Q4 | $96K | Sell |
36,206
-1,048
| -3% | -$2.78K | ﹤0.01% | 4010 |
|
|
2019
Q3 | $124K | Buy |
37,254
+15,268
| +69% | +$50.8K | ﹤0.01% | 4014 |
|
|
2019
Q2 | $132K | Buy |
21,986
+4,814
| +28% | +$28.9K | ﹤0.01% | 4026 |
|
|
2019
Q1 | $127K | Sell |
17,172
-331,955
| -95% | -$2.46M | ﹤0.01% | 3987 |
|
|
2018
Q4 | $112K | Sell |
349,127
-512,038
| -59% | -$164K | ﹤0.01% | 3987 |
|
|
2018
Q3 | $706K | Buy |
861,165
+2,700
| +0.3% | +$2.21K | ﹤0.01% | 3792 |
|
|
2018
Q2 | $884K | Sell |
858,465
-2,074
| -0.2% | -$2.14K | ﹤0.01% | 3721 |
|
|
2018
Q1 | $1.02M | Buy |
860,539
+1,310
| +0.2% | +$1.55K | ﹤0.01% | 3645 |
|
|
2017
Q4 | $8.05M | Buy |
859,229
+66,766
| +8% | +$626K | ﹤0.01% | 2921 |
|
|
2017
Q3 | $8.5M | Buy |
792,463
+111,413
| +16% | +$1.2M | ﹤0.01% | 2889 |
|
|
2017
Q2 | $6.99M | Sell |
681,050
-18,953
| -3% | -$194K | ﹤0.01% | 2945 |
|
|
2017
Q1 | $6.38M | Buy |
700,003
+19,973
| +3% | +$182K | ﹤0.01% | 2959 |
|
|
2016
Q4 | $8.5M | Buy |
680,030
+11,587
| +2% | +$145K | ﹤0.01% | 2820 |
|
|
2016
Q3 | $6.96M | Buy |
668,443
+203,690
| +44% | +$2.12M | ﹤0.01% | 2846 |
|
|
2016
Q2 | $4.7M | Buy |
464,753
+248,139
| +115% | +$2.51M | ﹤0.01% | 3018 |
|
|
2016
Q1 | $1.98M | Buy |
216,614
+61,170
| +39% | +$560K | ﹤0.01% | 3387 |
|
|
2015
Q4 | $1.94M | Buy |
+155,444
| New | +$1.94M | ﹤0.01% | 3405 |
|